-
Lactate Drives HMGB1 Lactylation and Release in Sepsis Macro
2026-05-31
This study reveals that lactate actively promotes the post-translational lactylation and acetylation of HMGB1 in macrophages during polymicrobial sepsis, leading to increased exosomal HMGB1 release. These findings illuminate a mechanistic link between metabolic changes and inflammatory signaling in sepsis, suggesting new therapeutic targets.
-
Brefeldin A: ATPase Inhibitor for ER–Golgi Trafficking Studi
2026-05-30
Brefeldin A (BFA) is a potent ATPase inhibitor that blocks ER-to-Golgi protein trafficking, induces ER stress, and selectively promotes apoptosis in cancer cell models. The B1400 kit from APExBIO is widely used for dissecting vesicular transport and cell death mechanisms, but proper workflow integration and awareness of its specificity are essential.
-
2'3'-cGAMP (sodium salt): Precision Tool for STING Pathway A
2026-05-29
2'3'-cGAMP (sodium salt) from APExBIO stands out for its unrivaled potency and specificity in activating the cGAS-STING pathway, making it the gold-standard for dissecting type I interferon induction and tumor immunology. Recent breakthroughs reveal its critical role in orchestrating endothelial-driven antitumor immunity, providing researchers with a high-fidelity platform for both mechanistic and translational studies.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X): Lab Use Guide
2026-05-29
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents protein degradation from serine, cysteine, and acid proteases during extraction and analysis workflows, especially where divalent cation preservation is critical. It is unsuitable for protocols requiring metalloprotease inhibition by chelation or those incompatible with DMSO.
-
Liproxstatin-1: Precision Ferroptosis Inhibitor for Cell Dea
2026-05-28
Liproxstatin-1 empowers ferroptosis research with nanomolar precision, enabling reproducible, selective inhibition of lipid peroxidation and regulated cell death in advanced model systems. This guide translates bench insights and reference advances into actionable protocols and troubleshooting strategies for optimized outcomes.
-
SP2509: Precision LSD1 Antagonist for Cancer Epigenetics
2026-05-28
Explore how SP2509, a potent Lysine-specific demethylase 1 antagonist, advances cancer epigenetics by enabling targeted modulation of histone methylation and apoptosis induction in acute myeloid leukemia research. This article uniquely dissects SP2509's mechanistic depth and assay design considerations.
-
TCF25 Regulates Lysosomal Acidification and Cell Fate in Glu
2026-05-27
Ren et al. identify TCF25 as a nutrient sensor that enhances lysosomal acidification via V-ATPase, orchestrating metabolic adaptation and cell death under glucose starvation. This mechanistic insight advances our understanding of how cells balance survival and death under metabolic stress, with implications for targeting metabolic and ischemic disorders.
-
CPI-613 (SKU A4333): Advancing Reliable Tumor Cell Metabolis
2026-05-27
This article details how CPI-613 (SKU A4333) addresses key laboratory challenges in apoptosis assays and tumor cell metabolism studies. Drawing on recent evidence and practical scenarios, we clarify protocol optimization, data interpretation, and product selection, demonstrating the value of validated mitochondrial metabolism inhibitors like CPI-613 for researchers in oncology.
-
LDN-193189: Optimizing ALK Inhibitor Use in BMP Pathway Rese
2026-05-26
LDN-193189 stands out as a nanomolar-potency ALK inhibitor, streamlining advanced studies of BMP signaling, epithelial barrier integrity, and heterotopic ossification. Learn how to integrate APExBIO’s LDN-193189 into reproducible, high-impact workflows—plus troubleshooting strategies for robust Smad pathway inhibition.
-
Phenylmethanesulfonyl Fluoride (PMSF): Precision in Protease
2026-05-26
Phenylmethanesulfonyl fluoride (PMSF) safeguards protein extracts by irreversibly inhibiting serine proteases, ensuring reliable Western blot and protein complex analyses. This article details robust experimental strategies, troubleshooting insights, and new advances drawn from recent eIF3 purification research.
-
Mubritinib (TAK 165): Disrupting Viral and Metabolic Depende
2026-05-25
Explore Mubritinib (TAK 165) as a dual-acting inhibitor targeting both mitochondrial metabolism and viral latency mechanisms. This article delves into its scientific rationale, unique experimental advantages, and practical guidance for advanced cancer and KSHV research.
-
MDL 28170: Rethinking Calpain Inhibition in Translational Mo
2026-05-25
This article explores the mechanistic and translational impact of MDL 28170, a selective calpain and cathepsin B inhibitor, with a focus on its application in neuroprotection, apoptosis assays, and disease modeling. Integrating recent evidence on BDNF/TrkB-mediated synaptic plasticity, it offers actionable guidance for researchers seeking to bridge the gap between mechanistic insight and real-world model optimization.
-
Leupeptin Hemisulfate Salt: Advanced Workflows in Protease R
2026-05-24
Leupeptin hemisulfate salt empowers precise regulation of serine and cysteine protease activity in protein degradation and viral inhibition studies. Integrating recent protocol innovations, this article details practical workflows, troubleshooting strategies, and comparative insights to maximize experimental reproducibility.
-
HDAC Inhibition Reverses EBV-Induced Plasticity in NPC Cells
2026-05-23
This article examines how HDAC inhibition counteracts Epstein-Barr virus (EBV)-driven dedifferentiation in nasopharyngeal carcinoma (NPC). By elucidating the involvement of LMP1, CEBPA repression, and chromatin remodeling, the study offers a mechanistic basis for differentiation therapy targeting cellular plasticity in solid tumors.
-
E-64 (SKU A2576): Enhancing Cysteine Protease Assays in Cell
2026-05-22
This scenario-driven guide examines real laboratory challenges in cysteine protease inhibition workflows and demonstrates how E-64 (SKU A2576) from APExBIO delivers reproducible, quantitative solutions. Researchers will discover practical insights for optimizing cell viability, cytotoxicity, and mechanistic assays using E-64’s validated potency and workflow compatibility.